Ethyl (E)-2-cyano-3-(4-methyl­phen­yl)acrylate: a second monoclinic polymorph

Por Chen, Qi-Yu, Ke, Wen-Dong, Kong, Lin
Publicado em 2013

Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue

Por Niu, Xiaoshuang, Chang, Xi, Gao, Yunsheng, Hu, Chaosu, Kong, Lin
Publicado em 2013

1-(4-Carb­oxy­phen­yl)-1H-imidazol-3-ium chloride dihydrate

Por Yu, Zhi-Peng, Geng, Wen-Qian, Kong, Lin, Zhou, Hong-Ping
Publicado em 2011

10-Ethyl-10H-phenothia­zine-3-carbaldehyde

Por Yu, Dao-Hui, Wang, Jian-Qing, Kong, Lin, Liu, Zhao-di
Publicado em 2011

Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma

Por Kong, Lin, Hu, Jiyi, Guan, Xiyin, Gao, Jing, Lu, Rong, Lu, Jiade J.
Publicado no J Cancer (2016)

Characteristics of Agraphia in Chinese Patients with Alzheimer's Disease and Amnestic Mild Cognitive Impairment

Por Zhou, Jiong, Jiang, Biao, Huang, Xian-Hong, Kong, Lin-Lin, Li, Hong-Lei
Publicado no Chin Med J (Engl) (2016)

Salvage Intensity-Modulated Radiation Therapy (IMRT) for Locally Recurrent Nasopharyngeal Cancer after Definitive IMRT: A Novel Scenario of the Modern Era

Por Kong, Lin, Wang, Lei, Shen, Chunying, Hu, Chaosu, Wang, Lei, Lu, Jiade J.
Publicado no Sci Rep (2016)

Anion-controlled dimer distance induced unique solid-state fluorescence of cyano substituted styrene pyridinium

Por Zhang, Gaobin, Zhang, Xuanjun, Kong, Lin, Wang, Shichao, Tian, Yupeng, Tao, Xutang, Yang, Jiaxiang
Publicado no Sci Rep (2016)

Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma

Por Kong, Lin, Gao, Jing, Hu, Jiyi, Hu, Weixu, Guan, Xiyin, Lu, Rong, Lu, Jiade J.
Publicado no Chin J Cancer (2016)

Involvement of both Cervical Lymph Nodes and Retropharyngeal Lymph Nodes has prognostic value for N1 patients with Nasopharyngeal Carcinoma

Por Shi, Qi, Shen, Chunying, Kong, Lin, Wang, Xiaoshen, Ding, Jianhui, Gao, Yunsheng, Xu, Tingting, Hu, Chaosu
Publicado em 2014

Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma

Por Liu, Bai, Kong, Lin, Marcus, Warren D, Chen, Xiaoyue, Han, Kaiping, Rhode, Peter R, Wong, Hing C
Publicado no J Immunother Cancer (2014)

The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas

Por Rosario, Maximillian, Liu, Bai, Kong, Lin, Schneider, Stephanie E, Jeng, Emily K, Rhode, Peter R, Wong, Hing C, Fehniger, Todd A
Publicado no J Immunother Cancer (2014)

Combination therapy of an IL-15 superagonist complex, ALT-803, and a tumor targeting monoclonal antibody promotes direct antitumor activity and protective vaccinal effect in a syng...

Por Chen, Xiaoyue, Liu, Bai, Han, Kaiping, Kong, Lin, Noel, Terra, Jeng, Emily K, Alter, Sarah, Rubinstein, Mark, Rhode, Peter R, Wong, Hing C
Publicado no J Immunother Cancer (2015)

Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of to...

Por Ou, Xiaomin, Zhou, Xin, Shi, Qi, Xing, Xing, Yang, Youqi, Xu, Tingting, Shen, Chunying, Wang, Xiaoshen, He, Xiayun, Kong, Lin, Ying, Hongmei, Hu, Chaosu
Publicado no Oncotarget (2015)

Novel antitumor mechanism-of-action of an IL-2 fusion protein mediated by tumor associated macrophage repolarization and innate-like CD8+ memory T cells

Por Xu, Wenxin, Egan, Jack O, Liu, Bai, Chen, Xiaoyue, You, Lijing, Han, Kaiping, Marcus, Warren D, Kong, Lin, Jones, Monica, Jeng, Emily K, Rhode, Peter R, Wong, Hing C
Publicado no J Immunother Cancer (2014)

Interleukin-15:Interleukin-15 receptor α scaffold for creation of multivalent targeted immune molecules

Por Wong, Richard L., Liu, Bai, Zhu, Xiaoyun, You, Lijing, Kong, Lin, Han, Kai-Ping, Lee, Hyung-il, Chavaillaz, Pierre-Andre, Jin, Moonsoo, Wang, Yi, Rhode, Peter R., Wong, Hing C.
Publicado em 2011

IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization

Por Han, Kai-ping, Zhu, Xiaoyun, Liu, Bai, Jeng, Emily, Kong, Lin, Yovandich, Jason L., Vyas, Vinay V., Marcus, Warren D., Chavaillaz, Pierre-Andre, Romero, Christian A., Rhode, Peter R., Wong, Hing C.
Publicado em 2011

Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor α/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma

Por Xu, Wenxin, Jones, Monica, Liu, Bai, Zhu, Xiaoyun, Johnson, C. Bryce, Edwards, Ana C., Kong, Lin, Jeng, Emily K., Han, Kaiping, Marcus, Warren D., Rubinstein, Mark P., Rhode, Peter R., Wong, Hing C.
Publicado em 2013

A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses

Por Liu, Bai, Kong, Lin, Han, Kaiping, Hong, Hao, Marcus, Warren D., Chen, Xiaoyue, Jeng, Emily K., Alter, Sarah, Zhu, Xiaoyun, Rubinstein, Mark P., Shi, Sixiang, Rhode, Peter R., Cai, Weibo, Wong, Hing C.
Publicado no J Biol Chem (2016)

Comparison of the super agonist complex, ALT-803, to IL-15 as cancer immunotherapeutics in animal models

Por Rhode, Peter R., Egan, Jack O., Xu, Wenxin, Hong, Hao, Webb, Gabriela M., Chen, Xiaoyue, Liu, Bai, Zhu, Xiaoyun, Wen, Jinghai, You, Lijing, Kong, Lin, Edwards, Ana C., Han, Kaiping, Shi, Sixiang, Alter, Sarah, Sacha, Jonah B., Jeng, Emily K., Cai, Weibo, Wong, Hing C.
Publicado no Cancer Immunol Res (2015)